A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma

Since 601A>G alters the potency of LTD4 and this variant allele may be associated with resistance to asthma, it is possible that modulation of the CYSLTR2 may be useful in asthma pharmacotherapy.